Alumis

Director Clinical Pharmacology & DMPK

Alumis  •  $200k - $240k/yr  •  South San Francisco, CA (Onsite)  •  21 days ago
Apply
AI can make mistakes so check important info. Chat history is never stored.
46
AI Success™

Job Description

Alumis Inc. is a precision medicines company with the mission to transform the lives of patients with autoimmune diseases. Even with treatment innovations of the last two decades, many patients with immunologic conditions continue to suffer - our goal is to fundamentally change the outcomes for these patients.

Alumis is seeking a Director of Clinical Pharmacology & DMPK to drive clinical pharmacology strategy and PK/PD modeling for our small-molecule programs in immune-mediated diseases. This role partners closely with cross-functional teams and reports to the Head of Clinical Pharmacology & DMPK.

Specific responsibilities include but are not limited to:

  • Lead clinical pharmacology strategy, dose selection, and PK/PD and biomarker planning across early and late-stage programs.
  • Conduct and interpret PK, PK/PD, exposure–response, and simulation analyses using tools such as NONMEM, WinNonlin, R, Python, and Simcyp.
  • Integrate translational and nonclinical PK/PD data to support FIH dose projections and DDI assessments.
  • Oversee bioanalytical CROs, ensuring high-quality PK/PD/biomarker data and GLP/GCP compliance.
  • Partner with Clinical Operations on sample management and protocol design.
  • Communicate quantitative findings clearly and contribute to regulatory documents (protocols, IBs, INDs, NDAs, IMPDs).
  • Collaborate across Clinical Development, Biostats/Data Science, Nonclinical, and Program Management.

Key Requirements and Qualifications

  • PhD, PharmD, or equivalent in Pharmacokinetics, Pharmacology, or related field.
  • 6 to 8+ years of industry experience in Clinical Pharmacology, DMPK, or Quantitative Pharmacology.
  • Strong expertise in PK, PK/PD, DMPK, and translational sciences.
  • Proficiency with modeling/simulation platforms (NONMEM, WinNonlin, Simcyp, R, Python).
  • Excellent communication, organization, and ability to work independently in a fast-paced environment.

Alumis Inc. is an equal opportunity employer.

The salary range for this position is $200,000 USD to $240,000 USD annually. This salary range is an estimate, and the actual salary may vary based on the Company’s compensation practices.

This position is located in South San Francisco, CA and employees are expected to be onsite Tuesday-Thursday.

Alumis compensation packages include generous stock option grants for all employees as well as an annual bonus program.

Other benefits include:

  • Health insurance premiums paid at 90% for employee, 80% for dependents
  • Free access to Genentech Bus Share program
  • $100 monthly cell phone stipend
  • Unlimited PTO for Exempt employees
  • Free onsite gym and a kitchen stocked with yummy snacks and drinks!

We are a hard-working, collaborative team on a mission to transform patient’s lives-- and we aspire to elevate, challenge and nurture one another along the way.

Alumis

About Alumis

At Alumis, our goal is to significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.

We recognize that patients living with immune-mediated diseases need alternatives to currently available therapies. Despite recent advances and innovations in the treatment of immune-mediated diseases, many patients continue to suffer, cycling through currently approved therapies while looking for a solution that alleviates the debilitating impact of their disease without life-limiting side effects.

Addressing the needs of these patients is why we exist. We are pioneering a precision approach that leverages insights we derive from powerful data analytics to select the right target, right molecule, right indication, right patient, and right endpoint resulting in optimized outcomes for patients. We believe that combining our insights with an integrated approach to drug development will produce the next generation of treatments to address immune dysfunction.

Incubated by Foresite Labs, Alumis is led by a team of deeply experienced professionals who are devoted to transforming the lives of patients with immune-mediated diseases by developing a pipeline of transformative therapies.

Industry
Biotech & Life Sciences
Company Size
201-500 employees
Headquarters
South San Francisco, California
Year Founded
2021
Social Media